IL1B and Bloom syndrome: As seen in Fig. 5A–F and Table 2, the model group dramatically lowered the secretion level of anti-inflammatory factors (IL-4, IL-10) and raised the secretion level of pro-inflammatory factors (TNF-α, IL-1, IL-18, and IL-6) in the serum of rats treated with BLM.